Published: Dec 21, 2021
Novavaxs vaccine was cleared by European regulators and is set to become the first Covid-19 shot of its kind in the region, giving countries another tool as they race to protect their populations in the face of the omicron variant.
Published: Aug 17, 2021
After Thammasat University councillors resolved on Monday to source Covid-19 vaccines, the university hospital’s director Dr Pharuhat Tor-Udom said this campaign will be much like the one run by Chulabhorn Royal Academy.
Published: Jan 29, 2021
WASHINGTON - A coronavirus vaccine made by Maryland biotech company Novavax proved effective at stopping infections in global hot spots where concerning variants are dominant, the company announced Thursday. But warning signs lurked amid those findings: The protective effect of the vaccine was substantially muted in South Africa, where a worrisome virus variant is in wide circulation.
Published: Dec 29, 2020
Novavax Inc. will start the final-stage trial of its coronavirus vaccine with 30,000 people in the U.S. and Mexico, opening another avenue for shots to fight the pandemic, the National Institute of Allergy and Infectious Diseases said.